Health

A Different Approach is Being Considered for Type 2 Diabetes

In this photo taken Wednesday, May 13, 2015, Weston Murphy, 5, who has Type 1 diabetes, pricks his finger to test his blood at his home in Plainfield, Ill. About 1.25 million Americans have Type 1 diabetes. Type 2 disease is more common, affecting nearly 30 million nationwide and most of the more than 300 million worldwide with diabetes. Besides short-term complications from poorly controlled blood sugar, both types raise long-term risks for damage to the kidneys, heart and eyes. (AP Photo/Nam Y. Huh)
In this photo taken Wednesday, May 13, 2015, Weston Murphy, 5, who has Type 1 diabetes, pricks his finger to test his blood at his home in Plainfield, Ill. (AP Photo/Nam Y. Huh)

 

(Apex Tribune) – One of the most common conditions could be battled with another form of treatment, as a different approach is being considered for type 2 diabetes that may help the millions of people afflicted gain control of the life altering disease.

According to the Centers for Disease Control and Prevention (CDC), in 2014, approximately 29 million people were diagnosed with diabetes only in the United States, which makes up for 12% of the country’s entire population, and around 90% of the cases are of type 2. The costs are astronomical, and the numbers are seeing no better prospect for the future.

Researchers at the Washington University School of Medicine have worked on a different strategy of approaching the disease, and found excellent results in mice. The new treatment implies lowering the production of glucose in the liver, by shutting down a protein involved in its making. It will essentially lower the blood sugar levels, and could be highly efficient in patients suffering from type 2 diabetes.

According to lead author of the study, Brian N. Finck, who is an associate professor of medicine at the Division of Geriatrics and Nutritional Science, the strategy could prove itself effective in creating new drugs to fight the most common form of diabetes, and might pave the way to better treatments.

READ MORE

Tags
Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Subscribe today for free and be the first to have news and information delivered directly to your inbox.

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker